Artist, 24, still in pain 4 years after being hit by a baseball bat at a Chicago Cubs training game

Alexandra Binkowski, 24, said she was hit in the head by a baseball bat during a Chicago Cubs spring training game in March 2015. She says she still suffers from daily, painful headaches.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Conclusion: Pregabalin has a better safety profile and tolerability compared to Duloxetine but the latter is more effective in treating Diabetic Peripheral Neuropathic Pain. However, further studies with a larger sample size and longer duration are required to be conducted for finding the effectiveness of these drugs, specifically in the Indian population. PMID: 31793266 [PubMed - in process]
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
ConclusionsThis review suggests that there are unmet needs for migraine in terms of sufficient and appropriate diagnosis, and better management and therapies for treatment of migraine in East Asia. The findings are limited by a lack of recent information and significant gaps in the literature. More recent, population-based studies assessing disease burden and clinical management of migraine are needed to confirm unmet needs for migraine across East Asia.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
Conclusion: Short-term follow-up of this study showed that lactulose syrup could remove the constipation with no significant side effects––can be used as an adjunct for the treatment of patients with migraine. However, future studies suggested for long-term consequences of constipation control.
Source: Journal of Pediatric Neurosciences - Category: Neuroscience Authors: Source Type: research
There’s been a lot of good news recently for people who experience migraines. In 2018, the U.S. Food and Drug Administration approved three drugs aimed to prevent migraines from occurring, and, over time, help to make them less frequent and less intense. Treating migraine pain while an attack is underway, however, is a bigger challenge. Triptans are the most popular medications used for this purpose, but they don’t work for everyone. In a study published in the New England Journal of Medicine, researchers report encouraging results with a promising class of oral drugs called gepants, which are meant to be taken...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized embargoed study Headache Migraine Source Type: news
WEDNESDAY, Dec. 4, 2019 -- The percentage of patients with migraine reporting freedom from pain is higher for those receiving ubrogepant than those receiving placebo, according to a study published in the Dec. 5 issue of the New England Journal of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Conditions:   Migraine;   Pain Intervention:   Other: Kinesiotaping Sponsor:   Medipol University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Migraine;   Pain Intervention:   Other: Kinesiotaping Sponsor:   Medipol University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Migraine;   Pain Intervention:   Other: Kinesiotaping Sponsor:   Medipol University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The team found that when it came to head pain control, it didn't matter how much tetrahydrocannabinol (THC) or cannabidiol (CBD) was in a particular batch of pot. THC and CBD are the most commonly studied ingredients in marijuana
Source: WebMD Health - Category: Consumer Health News Source Type: news
TUESDAY, Dec. 3, 2019 -- Inhaled cannabis reduces self-reported headache and migraine severity, according to a study published online Nov. 9 in the Journal of Pain. Carrie Cuttler, Ph.D., from Washington State University in Pullman, and colleagues...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Headache | Health | Pain | Training | Universities & Medical Training